Professional Documents
Culture Documents
Andon Hes3antoro
1. Bulun
SE,
Utsunomiya
H,
Lin
Z,
Yin
P,
Cheng
YH,
Pavone
ME,
Tokunaga
H,
Trukhacheva
E,
A^ar
E,
Gurates
B
et
al..
Steroidogenic
factor-1
and
endometriosis.
Mol
Cell
Endocrinol
2009;300:104
108
2. Cumiskey
J,
Whyte
P,
Kelehan
P,
Gibbons
D.
A
detailed
morphologic
and
immunohistochemical
comparison
of
pre-
and
postmenopausal
endometriosis.
J
Clin
Pathol
2008;61:455-459
3. Giudice
LC.
Endometriosis.
N
Engl
J
Med
2010;362:2389-2398
Its
is
a
disease
with
considerable
prevalence
in
communi6es
Prevalence
It
may
aect
10%
-
15%
of
women
in
reproduc6ve
age
and
35%
to
50%
of
women
with
pelvic
pain,
infer6lity
or
both.
(1)
1200
1000
800
0
Total
length
of
3me
with
Total
diagnos3c
delay
Length
of
3me
before
Length
of
3me
from
Length
of
3me
from
referral
symptoms
seeking
medical
help
consulta3on
in
primary
care
to
secondary
care
to
to
referral
to
secondary
care
diagnosis
Tradi6onal
herbs
used
for
relieving
What
are
the
cause
of
delayed
diagnosis
pain
:
15%
25%
35%
25%
Endometriosis
Stunted
Fetal
origin
adult
DM
disease
Endometriosis
Insulin
resistance
Vulnerable
Suscep3ble
Problem
in
managing
endometriosis
Early
diagnosis
and
prompt
treatment
Management
for
Preven3ng
delayed
treatment
adolescent
endometriosis
Preven3ng
recurrence
Start
from
the
beginning
(
during
pregnancy
)
A
!
B
!
Demethyla3on
of
ER
promoter